Versartis’ Twice-Monthly Somavaratan for Pediatric Growth Hormone Deficiency to be Featured in Oral and Poster Presentations at IMPE 2017
VERSARTIS (VSAR)
Last versartis earnings: 7/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.versartis.com/investor-relations
Company Research
Source: GlobeNewswire
MENLO PARK, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for growth hormone deficiency (GHD), announced that somavaratan data will be featured in an oral presentation and three posters during the 10th International Meeting of Pediatric Endocrinology (IMPE), to be held September 14-17, in Washington D.C. The abstracts are available on the IMPE 2017 website. “IMPE brings together pediatric endocrine specialists from around the world every four years, and serves as a great opportunity to further highlight the depth of our long-term experience with somavaratan treatment in children with GHD,” said Colin Hislop, MD, Chief Development Officer. “We now have over 400 patients exposed to somavaratan, some of whom have been on our product for four years. We have built the largest data set of any long-acting growth hor
Show less
Read more
Impact Snapshot
Event Time:
VSAR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VSAR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VSAR alerts
High impacting VERSARTIS news events
Weekly update
A roundup of the hottest topics